You are here

Stelara Shines in Three Year Crohn's Disease Study

Stelara Shines in Three Year Crohn's Disease Study

Submitted by admin on October 24, 2018 - 10:07am

Source:

CP Wire

News Tags:

Crohn's Disease

clinical trials

Headline:

Stelara Shines in Three Year Crohn's Disease Study

snippet:

60.3% of all randomised ustekinumab-treated patients who entered the long-term extension study were in clinical remission at week 152
Of those patients who were naïve to TNF antagonist therapy and treated with ustekinumab, 67.6% were in clinical remission at week 156